These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 15827276)

  • 1. Emergence of atovaquone-proguanil resistance during treatment of Plasmodium falciparum malaria acquired by a non-immune north American traveller to west Africa.
    Kuhn S; Gill MJ; Kain KC
    Am J Trop Med Hyg; 2005 Apr; 72(4):407-9. PubMed ID: 15827276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic confirmation of atovaquone-proguanil-resistant Plasmodium falciparum malaria acquired by a nonimmune traveler to East Africa.
    Schwartz E; Bujanover S; Kain KC
    Clin Infect Dis; 2003 Aug; 37(3):450-1. PubMed ID: 12884171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analyses of cytochrome b mutations in Plasmodium falciparum isolates in Thai-Myanmar border.
    Naoshima-Ishibashi Y; Iwagami M; Kawazu S; Looareesuwan S; Kano S
    Travel Med Infect Dis; 2007 Mar; 5(2):132-4. PubMed ID: 17298921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for mutations related to atovaquone/proguanil resistance in treatment failures and other imported isolates of Plasmodium falciparum in Europe.
    Wichmann O; Muehlberger N; Jelinek T; Alifrangis M; Peyerl-Hoffmann G; Muhlen M; Grobusch MP; Gascon J; Matteelli A; Laferl H; Bisoffi Z; Ehrhardt S; Cuadros J; Hatz C; Gjorup I; McWhinney P; Beran J; da Cunha S; Schulze M; Kollaritsch H; Kern P; Fry G; Richter J;
    J Infect Dis; 2004 Nov; 190(9):1541-6. PubMed ID: 15478057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atovaquone + proguanil: new preparation. Second-line antimalarial combination.
    Prescrire Int; 2002 Oct; 11(61):131-6. PubMed ID: 12378742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apparent absence of atovaquone/proguanil resistance in 477 Plasmodium falciparum isolates from untreated French travellers.
    Musset L; Pradines B; Parzy D; Durand R; Bigot P; Le Bras J
    J Antimicrob Chemother; 2006 Jan; 57(1):110-5. PubMed ID: 16319183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atovaquone/proguanil for the prophylaxis and treatment of malaria.
    Patel SN; Kain KC
    Expert Rev Anti Infect Ther; 2005 Dec; 3(6):849-61. PubMed ID: 16307498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Atovaquone/proguanil. Prophylaxis and treatment of malaria].
    Lundgren JD; Dragsted UB
    Ugeskr Laeger; 2000 Jul; 162(31):4177-81. PubMed ID: 10962933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [What is the value of the combination atovaquone-proguanil for the clinician?].
    Delmont J
    Med Trop (Mars); 2002; 62(3):232-6. PubMed ID: 12244917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atovaquone/proguanil resistance in Africa: a case report.
    David KP; Alifrangis M; Salanti A; Vestergaard LS; Rønn A; Bygbjerg IB
    Scand J Infect Dis; 2003; 35(11-12):897-8. PubMed ID: 14723376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atovaquone/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunity.
    Lacy MD; Maguire JD; Barcus MJ; Ling J; Bangs MJ; Gramzinski R; Basri H; Sismadi P; Miller GB; Chulay JD; Fryauff DJ; Hoffman SL; Baird JK
    Clin Infect Dis; 2002 Nov; 35(9):e92-5. PubMed ID: 12384852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Plasmodium falciparum cytochrome b gene mutations in isolates imported from Africa, and implications for atovaquone resistance.
    Berry A; Senescau A; Lelièvre J; Benoit-Vical F; Fabre R; Marchou B; Magnaval JF
    Trans R Soc Trop Med Hyg; 2006 Oct; 100(10):986-8. PubMed ID: 16690094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia.
    Ling J; Baird JK; Fryauff DJ; Sismadi P; Bangs MJ; Lacy M; Barcus MJ; Gramzinski R; Maguire JD; Kumusumangsih M; Miller GB; Jones TR; Chulay JD; Hoffman SL;
    Clin Infect Dis; 2002 Oct; 35(7):825-33. PubMed ID: 12228819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of atovaquone-proguanil for treatment of acute multidrug-resistant Plasmodium falciparum malaria in Thailand.
    Krudsood S; Patel SN; Tangpukdee N; Thanachartwet W; Leowattana W; Pornpininworakij K; Boggild AK; Looareesuwan S; Kain KC
    Am J Trop Med Hyg; 2007 Apr; 76(4):655-8. PubMed ID: 17426165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atovaquone-proguanil compared with chloroquine and chloroquine-sulfadoxine-pyrimethamine for treatment of acute Plasmodium falciparum malaria in the Philippines.
    Bustos DG; Canfield CJ; Canete-Miguel E; Hutchinson DB
    J Infect Dis; 1999 Jun; 179(6):1587-90. PubMed ID: 10228090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atovaquone-proguanil resistance in imported falciparum malaria in a young child.
    Rose GW; Suh KN; Kain KC; Le Saux N; McCarthy AE
    Pediatr Infect Dis J; 2008 Jun; 27(6):567-9. PubMed ID: 18434932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Confirmation of emergence of mutations associated with atovaquone-proguanil resistance in unexposed Plasmodium falciparum isolates from Africa.
    Happi CT; Gbotosho GO; Folarin OA; Milner D; Sarr O; Sowunmi A; Kyle DE; Milhous WK; Wirth DF; Oduola AM
    Malar J; 2006 Oct; 5():82. PubMed ID: 17020611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of uncomplicated multidrug-resistant falciparum malaria with artesunate-atovaquone-proguanil.
    van Vugt M; Leonardi E; Phaipun L; Slight T; Thway KL; McGready R; Brockman A; Villegas L; Looareesuwan S; White NJ; Nosten F
    Clin Infect Dis; 2002 Dec; 35(12):1498-504. PubMed ID: 12471569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study.
    Overbosch D; Schilthuis H; Bienzle U; Behrens RH; Kain KC; Clarke PD; Toovey S; Knobloch J; Nothdurft HD; Shaw D; Roskell NS; Chulay JD;
    Clin Infect Dis; 2001 Oct; 33(7):1015-21. PubMed ID: 11528574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short report: no evidence of cardiotoxicity of atovaquone-proguanil alone or in combination with artesunate.
    Gupta RK; Van Vugt M; Paiphun L; Slight T; Looareesuwan S; White NJ; Nosten F
    Am J Trop Med Hyg; 2005 Aug; 73(2):267-8. PubMed ID: 16103586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.